Outset Medical Inc OM.OQ OM.O is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The San Jose California-based company is expected to report a 1.3% decrease in revenue to $27.812 million from $28.17 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Outset Medical Inc is for a loss of 94 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 0.6% in the last three months. ‚Äč
Wall Street's median 12-month price target for Outset Medical Inc is $15.00‚Äč, above‚Äč its last closing price of $12.25. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-6.15
-6.19
-5.55
Beat
10.3
Sep. 30 2024
-6.37
-6.33
-5.85
Beat
7.5
Jun. 30 2024
-6.76
-6.78
-7.05
Missed
-4.1‚Äč
Mar. 31 2024
-8.47
-8.23
-8.55
Missed
-3.9
‚Äč‚ÄčDec. 31 2023
-9.20
-9.22
-8.85
Beat
4.1
Sep. 30 2023
-9.98
-10.00
-10.65
Missed
-6.5‚Äč
Jun. 30 2023
-12.53
-11.44
-13.50
Missed
-18
Mar. 31 2023
-11.68
-11.13
-13.50
Missed
-21.3
This summary was machine generated May 5 at 20:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)